Allelotype of posterior uveal melanoma: Implications for a bifurcated tumor progression pathway

Cancer Research

Volumn 59, Issue 13, 1999, Pages 3032-3037

  Parrella, Paola ^a,b   Sidransky, David ^b   Merbs, Shannath L ^c  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b Div of Hd and Neck Cancer Research   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROSATELLITE DNA;

ALLOTYPE; ARTICLE; CHROMOSOME 3; CHROMOSOME 6P; CHROMOSOME LOSS; FEMALE; GENETIC MARKER; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR GROWTH; UVEA MELANOMA;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 6; CHROMOSOMES, HUMAN, PAIR 8; DISEASE PROGRESSION; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MELANOMA; MICROSATELLITE REPEATS; UVEAL NEOPLASMS; X CHROMOSOME;

EID: 0033168843     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Scotto, J., Fraumeni, J. F., and Lee, J. A. H. Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J. Natl. Cancer Inst., 56: 489-491, 1976.
2. Diener-West, M., Hawkins, B. S., Markowitz, J. A., and Schachat, A. P. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch. Ophthalmol., 77: 245-250, 1993.
3. Brown, D., Boniuk, M., and Font, R. Diffuse malignant melanoma of iris with metastases. Surv. Ophthalmol., 34: 357-364, 1990.
4. Jensen, O. A. Malignant melanomas of the human uvea: 25-year follow-up of cases in Denmark, 1943-1952. Acta Ophthalmol., 60: 161-182, 1981.
5. Kath, R., Hayungs, J., Bornfeld, N., Sauerwein, W., Höffken, K., and Seeber, S. Prognosis and treatment of disseminated uveal melanoma. Cancer (Phila.), 72: 2219-2223, 1993.
6. Vogelstein, B., and Kinzler, K. W. (eds.). The Genetic Basis of Human Cancer. New York: McGraw-Hill, 1998.
7. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
8. Becher, R., Korn, W. M., and Prescher, G. Use of fluorescent in situ hybridization and comparative genomic hybridization in the cytogenetic analysis of testicular germ cell tumors and uveal melanomas. Cancer Genet. Cytogenet., 93: 22-28, 1997.
9. Speicher, M. R., Prescher, G., du Manoir, S., Jauch, A., Horsthemke, B., Bornfeld, N., Becher, R., and Cremer, T. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization. Cancer Res., 54: 3817-3823, 1994.
10. Gordon, K. B., Thompson, C. T., Char, D. H., O'Brien, J. M., Kroll, S., Ghazvini, S., and Gray, J. W. Comparative genomic hybridization in the detection of DNA copy number abnormalities in uveal melanoma. Cancer Res., 54: 4764-4768, 1994.
11. Ghazvini, S., Char, D. H., Kroll, S., Waldman, F. M., and Pinkel, D. Comparative genomic hybridization analysis of archival formalin-fixed paraffin-embedded uveal melanomas. Cancer Genet. Cytogenet., 90: 95-101, 1996.
12. McNamara, M., Felix, C., Davison, E. V., Fenton, M., and Kennedy, S. M. Assessment of chromosome 3 copy number in ocular melanoma using fluorescent in situ hybridization. Cancer Genet. Cytogenet. 98: 4-8, 1997.
13. White, V. A., McNeil, K., and Horsman, D. Acquired homozygosity (isodisomy) of chromosome 3 in uveal melanoma. Cancer Genet. Cytogenet., 102: 40-45, 1998.
14. The Collaborative Ocular Melanoma Study Group. Design and methods of a clinical trial for a rare condition: the collaborative ocular melanoma study. COMS Report No. 3. Controlled Clin. Trials, 14: 362-391, 1993.
15. Mclean, I. W., Foster, W. D., and Zimmerman, L. E. Uveal melanoma: location, size, cell type and enucleation as risk factor in metastasis. Hum. Pathol., 13: 123-132, 1983.
16. Merbs, S. M., and Sidransky, D. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma. Invest. Ophthalmol. Visual Sci., 40: 779-83, 1999.
17. van der Riet, P., Nawroz, H., Hruban, R. H., Corio, R., Tokino, K., Koch, W., and Sidransky, D. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res., 54: 1156-1158, 1994.
18. Healy, E., Belgaid, C. E., Takata, M., Vahlquist, A., Rehman, I., Rigby, H., and Rees, J. L. Allelotypes of primary cutaneous melanoma and benign melanocytic nevi. Cancer Res., 56: 589-593, 1996.
19. Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F. M., Orcutt, M. L., Stachouse, T., Kuzmin, I., Modi, W., Geil, L., Schmidt, L., Zhou, F., Li, H., Wei, M. H., Chen, F., Glenn, G., Choyke, P., Walther, M. M., Weng, Y., Duan, D. S. R., Dean, M., Glavac, D., Richards, F. M., Crossey, P. A., Ferguson-Smith, M. A., Le Paslier, D., Chumakov, I., Cohen, D., Chinault, A. C., Maher, E. R., Linehan, W. M., Zbar, B., and Lerman, M. I. Identification of the von Nippel-Lindau disease tumor suppressor gene. Science (Washington DC), 260: 1317-1320, 1993.
20. Ohta, M., Inoue, H., Cotticelli, M. G., Kastury, K., Baffa, R., Palazzo, J., Siprashvili, Z., Mori, M., McCue, P., Druck, T., Croce, C. M., and Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 84: 587-597, 1996.
21. Weinberg, C., Thompson, C. C., Ong, E. S., Lebo, R., Gruol, D. J., and Evans, R. M. The c-erb-A gene encodes a thyroid hormone receptor. Nature (Lond.), 324: 641-646, 1986.
22. Prescher, G., Bornfeld, N., and Becher, R. Nonrandom abnormalities in primary uveal melanoma. J. Natl. Cancer Inst., 82: 1765-1769, 1990.
23. 1 cyclin-dependent kinase. Cell, 75: 805-816, 1993.
24. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parson, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1 a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
25. Gorospe, M., Cirielli, C., Wang, X., Seth, P., Capogrossi, M. C., and Holbrook, N. J. p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene, 14: 929-935, 1997.
26. Karjalainen, J. M., Eskelinen, M. J., Kellokoski, J. K., Reinikainen, M., Alhava, E. M., and Kosma, V. M. p21(WAF1/CIP1) expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival. Br. J. Cancer, 79: 895-902, 1999.
27. Blom, D. J. R., Schurmans, L. R. H. M., de Waard-Siebinga, I., De Wolff-Rouendaal, D., Keunen, I. E. E., and Jager, M. J. HLA expression in a primary uveal melanoma, its cell line and four of its metastases. Br. J. Ophthalmol., 81: 989-993, 1997.
28. Horsman, D. E., Sroka, H., Rootman, J., and White, V. A. Monosomy 3 and isochromosome 8q in uveal melanoma. Cancer Genet. Cytogenet., 45: 249-253, 1990.
29. Prescher, C., Bornfeld, N., Hirche, H., Horsthemke, B., Jöckel, K-H., and Becher, R. Prognostic implications of monosomy 3 in uveal melanoma. Lancet, 347: 1222-1225, 1996.
30. Sisley, K., Rennie, I. G., Parsons, A., Jacques, R., Hammond, D. W., Bell, S. M., Potter, A. M., and Rees, R. C. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer, 19: 22-28, 1997.
31. White, V. A., Chambers, J. D., Courtright, P. D., Chang, W. Y., and Horsman, D. E. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer (Phila.), 83: 354-359, 1998.
32. Ohta, M., Berd, D., Shimizu, M., Nagai, H., Cotticelli, M-G., Mastrangelo, M., Shields, J. A., Sheilds, C. L., Croce, C. M., and Huebner, K. Deletion mapping of chromosome region 9p21-p22 surrounding the CDNK2 locus in melanoma. Int. J. Cancer. 65: 762-767, 1996.
33. Sisley, K., Nichols, C., Parsons, M. A., Farr, R., Rees, R. C., and Rennie, I. G. Clinical applications of chromosome analysis, from fine needle aspiration biopsies, of posterior uveal melanomas. Eye (Lond.), 12: 203-207, 1998.
34. Nawroz, H., Koch, W., Anker, P., Stroun, M., and Sidransky, D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat. Med., 2: 1035-1037, 1996.
35. Chen, X. Q., Stroun, M., Manenat, J. L., Nicod, L. P., Kurt, A. M., Lyautey, J., Lederrey, C., and Anker, P. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med., 2: 1033-1034, 1996.
36. Hibi, K., Robinson, C. R., Booker, S., Wu. L., Hamilton, S. R., Sidransky, D., and Jen, J. Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res., 58: 1405-1407, 1998.
37. Fujiwara, Y., Chi, D. D. J., Wang, H., Keleman, P., Morton, D. L., Turner, R., and Hoon, D. S. B. Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients. Cancer Res., 59: 1567-1571, 1999.